Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,5-dicaffeoylquinic Acid
2. 1-carboxy-4,5-dihydroxy-1,3-cyclohexylenebis-(3,4-dihydroxycinnamate)
3. Cinarin
4. Cinarina
5. Cinarine
6. Cynarex
7. Cynarin
8. Cynarin, (1alpha,3alpha,4alpha,5beta)-isomer
9. Cynarix
10. Listricol
11. Listrocol
12. Nivellipid
13. Phemocil
1. Cynarin
2. 30964-13-7
3. Cinarine
4. 1,5-dicaffeoylquinic Acid
5. 1,3-dicaffeoylquinic Acid
6. Cynarine [inn]
7. Cynarine [mi]
8. Plemocil
9. (1r,3r,4s,5r)-1,3-bis((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-4,5-dihydroxycyclohexanecarboxylic Acid
10. Cynarine [mart.]
11. 212891-05-9
12. Cynarine [who-dd]
13. 1,3-dicqa
14. Chebi:520
15. 85d81u9jav
16. Cinarin
17. 1884-23-7
18. Caffeic Acid 1-carboxy-4,5-dihydroxy-1,3-cyclohexylene Ester
19. 1-carboxy-4,5-dihydroxy-1,3-cyclohexylenebis-(3,4-dihydroxycinnamate)
20. (1r,3r,4s,5r)-1,3-bis[[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-4,5-dihydroxycyclohexane-1-carboxylic Acid
21. 1,5-di-o-caffeoylquinic Acid
22. Phemocil
23. 3,4-dihydroxycinnamic Acid 1-carboxy-4,5-dihydroxy-1,3-cyclohexylene Ester
24. 3,4-dihydroxycinnamic Acid, 1-carboxy-4,5-dihydroxy-1,3-cyclohexylene Ester
25. (1r,3r,4s,5r)-1,3-bis(((e)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)-4,5-dihydroxycyclohexane-1-carboxylic Acid
26. (1r,3r,4s,5r)-1,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-4,5-dihydroxycyclohexanecarboxylic Acid
27. (1r,3r,4s,5r)-1,3-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4,5-dihydroxycyclohexane-1-carboxylic Acid
28. 1,3-dicaffeoylquinic Acid (constituent Of Echinacea Angustifolia Root, Echinacea Pallida Root, Echinacea Purpurea Root And Echinacea Purpurea Aerial Parts) [dsc]
29. Cyclohexanecarboxylic Acid, 1,3-bis(((2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-4,5-dihydroxy-, (1r,3r,4s,5r)-
30. 1,5-dicaffeoylqunic Acid
31. Unii-85d81u9jav
32. Cynaricine
33. Quinic Acid 1,5-dicaffeic Ester
34. Cynarin, Analytical Standard
35. Schembl42528
36. 1_5_dihydrocaffeoylquinic_acid
37. Chembl487258
38. Dtxsid301309674
39. Bcp29379
40. Hy-n0359
41. Zinc4098728
42. Bdbm50369484
43. S3301
44. Akos015912727
45. Ac-6022
46. Cs-6280
47. As-74959
48. N2812
49. 1,3-dicaffeoylquinic Acid, >=98% (hplc)
50. A820670
51. J-003723
52. Q-100389
53. Q1763092
54. Cynarine;1,3-dicaffeoylquinic Acid;1,5-dqa;1,5-dicaffeoylquinic Acid
55. (1r,3r,4s,5r)-1,3-bis((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-4,5-dihydroxycyclohexanecarboxylicacid
56. (1r,3r,4s,5r)-1,3-bis{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexane-1-carboxylic Acid
57. (1r-(1.alpha.,3.alpha.,4.alpha.,5.beta.))-1,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-4,5-dihydroxycyclohexanecarboxylic Acid
58. (1r-(1alpha,3alpha,4alpha,5beta))-1,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-4,5-dihydroxycyclohexanecarboxylic Acid
59. 1,3beta-bis[(e)-3-(3,4-dihydroxyphenyl)acryloyloxy]-4beta,5alpha-dihydroxycyclohexane-1alpha-carboxylic Acid
60. Cyclohexanecarboxylic Acid, 1,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-4,5-dihydroxy-
61. Cyclohexanecarboxylic Acid,1,3-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-4,5-dihydroxy-,(1r,3r,4s,5r)-
| Molecular Weight | 516.4 g/mol |
|---|---|
| Molecular Formula | C25H24O12 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 9 |
| Exact Mass | 516.12677620 g/mol |
| Monoisotopic Mass | 516.12677620 g/mol |
| Topological Polar Surface Area | 211 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 887 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Cholagogues and Choleretics
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Cynarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cynarin, including repackagers and relabelers. The FDA regulates Cynarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cynarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cynarin supplier is an individual or a company that provides Cynarin active pharmaceutical ingredient (API) or Cynarin finished formulations upon request. The Cynarin suppliers may include Cynarin API manufacturers, exporters, distributors and traders.
Cynarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cynarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cynarin GMP manufacturer or Cynarin GMP API supplier for your needs.
A Cynarin CoA (Certificate of Analysis) is a formal document that attests to Cynarin's compliance with Cynarin specifications and serves as a tool for batch-level quality control.
Cynarin CoA mostly includes findings from lab analyses of a specific batch. For each Cynarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cynarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Cynarin EP), Cynarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cynarin USP).
LOOKING FOR A SUPPLIER?
